Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 21677258.
- Also identified by DOI 10.1093/cid/cir400 and PMC identifier 3137795.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An independent reanalysis of 11 randomized clinical trials shows that oseltamivir treatment reduces the risk of lower respiratory tract complications requiring antibiotic treatment by 28% overall (95% confidence interval [CI], 11%-42%) and by 37% among patients with confirmed influenza infections (95% CI, 18%-52%).
Medical subject headings
- Antiviral Agents
- Influenza, Human
- Oseltamivir
- Pneumonia, Bacterial